We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$269M
AUM Growth
–
Cap. Flow
+$264M
Cap. Flow %
98.02%
Top 10 Hldgs %
27.65%
Holding
112
New
112
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CLDX icon
Celldex Therapeutics
CLDX
+$10.8M
2
RH icon
RH
RH
+$10.3M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.56M
4
AAPL icon
Apple
AAPL
+$6.29M
5
EPD icon
Enterprise Products Partners
EPD
+$6.18M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 22.57%
2 Energy 19.28%
3 Communication Services 12.18%
4 Industrials 9.72%
5 Technology 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDS.A
51
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.18M 0.81%
+36,583
New +$2.26M
CMCSA icon
52
Comcast
CMCSA
$96B
$2.09M 0.78%
+100,200
New +$2.07M
REGN icon
53
Regeneron Pharmaceuticals
REGN
$81.8B
$2.08M 0.77%
+9,250
New +$2.15M
MON
54
DELISTED
Monsanto Co
MON
$2.06M 0.76%
+20,820
New +$2.18M
BRG
55
DELISTED
BG GROUP PLC ADS(RP 5 ORD SHS)
BRG
$1.93M 0.72%
+113,850
New +$1.93M
NDLS icon
56
Noodles & Co
NDLS
$88.2M
$1.78M 0.66%
+6,063
New +$1.78M
ABBV icon
57
AbbVie
ABBV
$451B
$1.7M 0.63%
+41,050
New +$1.8M
MDXG icon
58
MiMedx Group
MDXG
$656M
$1.68M 0.63%
+238,436
New +$1.67M
DVY icon
59
iShares Select Dividend ETF
DVY
$23.8B
$1.68M 0.62%
+26,175
New +$1.69M
MDCO
60
DELISTED
Medicines Co
MDCO
$1.59M 0.59%
+51,621
New +$1.73M
SDR
61
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$1.55M 0.58%
+124,100
New +$1.54M
PER
62
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$1.45M 0.54%
+97,450
New +$1.4M
ABT icon
63
Abbott
ABT
$195B
$1.44M 0.53%
+41,250
New +$1.51M
DT
64
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
$1.32M 0.49%
+113,055
New +$1.32M
VVUS
65
DELISTED
Vivus Inc
VVUS
$1.26M 0.47%
+10,000
New +$1.29M
ONXX
66
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
$1.2M 0.44%
+13,800
New +$1.27M
MWV
67
DELISTED
MEADWESTVACO CORP
MWV
$1.09M 0.4%
+31,909
New +$1.12M
CEF icon
68
Sprott Physical Gold and Silver Trust
CEF
$7.99B
$1.08M 0.4%
+79,400
New +$1.29M
OMC icon
69
Omnicom Group
OMC
$24.2B
$1.01M 0.37%
+16,000
New +$981K
JNJ icon
70
Johnson & Johnson
JNJ
$646B
$966K 0.36%
+11,246
New +$954K
NUAN
71
DELISTED
Nuance Communications, Inc.
NUAN
$926K 0.34%
+58,151
New +$991K
CELG
72
DELISTED
Celgene Corp
CELG
$877K 0.33%
+15,000
New +$903K
QCOR
73
DELISTED
QUESTCOR PHARMA INC
QCOR
$791K 0.29%
+17,400
New +$617K
OXY icon
74
Occidental Petroleum
OXY
$59.1B
$700K 0.26%
+8,194
New +$692K
VIRX
75
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$654K 0.24%
+600
New +$669K
1 2
3
4 5

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Private Capital Advisors, which disclosed 112 positions worth $269M. Its ten largest holdings account for 28% of the portfolio.

Its largest position is Celldex Therapeutics: 54,837 shares worth $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, followed by Energy and Communication Services.

  • Private Capital Advisors's largest Q2 2013 buy was Celldex Therapeutics: 54,837 shares worth $12.8M.
  • Private Capital Advisors's ten largest holdings make up 28% of its $269M portfolio in Q2 2013.
  • Private Capital Advisors disclosed 112 positions in Q2 2013, its first 13F filing on record.

Based on Private Capital Advisors's 13F filing for Q2 2013, filed 24 Jul 2013.